Blueshift Asset Management, LLC Infinity Pharmaceuticals, Inc. Transaction History

Blueshift Asset Management, LLC

  • $392 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$1.86 - $3.36 $40,192 - $72,606
-21,609 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$1.52 - $3.82 $32,845 - $82,546
21,609 New
21,609 $74,000

Others Institutions Holding INFI

# of Institutions
3
Shares Held
1.26M
Call Options Held
0
Put Options Held
0
View Full List

About INFINITY PHARMACEUTICALS, INC.

INFI Quotes by TradingView
  • Ticker INFI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 89,277,904
  • Description
  • Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...
More about INFI
Track This Portfolio

Track Blueshift Asset Management, LLC Portfolio

Follow Blueshift Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueshift Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email